BioReperia AB

Pdf

My visitor profile

BioReperia AB

Description of your activity

  • BioReperia accelerates oncology drug development with a next-generation in-vivo platform using zebrafish embryos. Our fast, clinically relevant models provide efficacy data in just 5 days, supporting target validation, lead optimization, and precision medicine strategies, while reducing reliance on traditional animal models.

More information

  • ๐—ฅ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป๐—ถ๐˜‡๐—ถ๐—ป๐—ด ๐——๐—ฟ๐˜‚๐—ด ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐˜„๐—ถ๐˜๐—ต ๐—•๐—ถ๐—ผ๐—ฅ๐—ฒ๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฎโ€™๐˜€ ๐—ก๐—ฒ๐˜…๐˜-๐—š๐—ฒ๐—ป๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—œ๐—ป-๐—ฉ๐—ถ๐˜ƒ๐—ผ ๐—ฃ๐—น๐—ฎ๐˜๐—ณ๐—ผ๐—ฟ๐—บ

    Innovation is essential to accelerate timelines and de-risk development in todayโ€™s pharmaceutical landscape. BioReperiaโ€™s cutting-edge in-vivo platform offers a rapid, clinically relevant, and highly translational solution to support your pipeline at every critical stage.

    ๐—ง๐—ฎ๐—ฟ๐—ด๐—ฒ๐˜ ๐—ฉ๐—ฎ๐—น๐—ถ๐—ฑ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐˜„๐—ถ๐˜๐—ต ๐—ฃ๐—ฟ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—ฆ๐—ฝ๐—ฒ๐—ฒ๐—ฑ
    Gain actionable efficacy data in just 5 days. Our models assess both tumor regression and metastasis dissemination using CDX, PDX, and primary patient tumors; enabling confident, early-stage decision-making.

    ๐—–๐—ผ๐—บ๐—ฝ๐—ฟ๐—ฒ๐—ต๐—ฒ๐—ป๐˜€๐—ถ๐˜ƒ๐—ฒ ๐—ฆ๐—ฐ๐—ฟ๐—ฒ๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—ณ๐—ผ๐—ฟ ๐—”๐—น๐—น ๐—ง๐—ต๐—ฒ๐—ฟ๐—ฎ๐—ฝ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ ๐— ๐—ผ๐—ฑ๐—ฎ๐—น๐—ถ๐˜๐—ถ๐—ฒ๐˜€
    From small molecules and peptides to antibodies, ADCs, and immunotherapies, our versatile platform supports screening across your entire portfolio within a single validated system.

    ๐—”๐—ฐ๐—ฐ๐—ฒ๐—น๐—ฒ๐—ฟ๐—ฎ๐˜๐—ถ๐—ป๐—ด ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น ๐—ฅ๐—ฒ๐—ฎ๐—ฑ๐—ถ๐—ป๐—ฒ๐˜€๐˜€
    ย ย โ€ข Translational Accuracy: PDX and patient tumor models deliver insights that mirror clinical outcomes.

    ย ย โ€ข Precision Medicine-Ready: CE-certified and proven to help identify the right patients, faster.

    ย ย โ€ข Speed to First-in-Human: Rapid results enable timely go/no-go decisions, shortening the path to clinical trials.

    Collaborate with us to de-risk development, optimize resources, and bring transformative therapies to patients, faster.

Participation objectives

Partnering objectives

  • Network development, Customer development

Description of my participation objective

  • We aim to understand current pain points in oncology drug development, explore collaboration opportunities, build lasting partnerships, and raise awareness of zebrafish embryos as a powerful and ethical alternative to traditional animal models.

Communication materials